Dr. Arevitalize Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.2/10
Best for: an oral route if you will not self-inject
Dr. Arevitalize's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
then $319/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
Charged on top
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Dr. Arevitalize (Dr.Arevitalize Health, Inc.) starts compounded semaglutide at $269/mo and tirzepatide at $349/mo, sold in 1-, 3-, 6- and 12-month bundles. The LegitScript-certified platform offers compounded GLP-1 medication in both injectable and oral-capsule forms, the capsules a needle-free alternative to injections. Care is clinician-guided, with lab and bloodwork analysis and personalized plans.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to Dr. Arevitalize
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Dr. Arevitalize at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $269/mo
- What's included
- Medication
- FDA status
- No FDA warning letter on record
How Dr. Arevitalize scores
Six columns, each one computed from something Dr. Arevitalize has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
3.1/10$349/month is 31% above the register median of $267 for compounded tirzepatide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
7.5/10On the seller's own pages, a price is published before the questionnaire starts; baseline bloodwork is required before a prescription.
Trust & Safety15%
6.5/10does not name a dispensing pharmacy; shows a price before asking for health information. Our verification confidence is medium.
Accessibility10%
5.0/10Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.
Support10%
3.0/10The price covers medication.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on Dr. Arevitalize
Last checked July 2026- Re-read the price on file across 4 dose or plan tiers
- Established what the monthly figure covers, and what it leaves out
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with Dr. Arevitalize involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1Dr. Arevitalize publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake requires baseline bloodwork, which is more than most of the register asks and slower to complete.
- 3Dr. Arevitalize does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- 4The monthly price is recorded as covering medication.
- Cheapest standing monthly prices on record: semaglutide $319, tirzepatide $349. Membership fees, first-month rates and insured copays are excluded from those figures.
- No state list is published, so whether Dr. Arevitalize serves your state cannot be confirmed from its site.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
GLP-1 medications Dr. Arevitalize offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here was read off Dr. Arevitalize's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication
- No FDA warning letter matched this operator when we searched our enforcement register
- Baseline bloodwork is required before a prescription
Against it
- Semaglutide at $319 a month, 69% above the $189 register median for the same drug and form
- Billed separately from the monthly figure: shipping
- No state list is on record here, so whether it serves your state cannot be confirmed from this page
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Dr. Arevitalize charges
Dr. Arevitalize advertises $269. That buys the first month. The standing rate is $319/month, and that is the one worth doing arithmetic on, because the introductory figure applies once.
- Compounded semaglutide — $269 first month, then $319/month
- Compounded tirzepatide — $359/month
- Compounded semaglutide — $299 first month, then $349/month
- Compounded tirzepatide — $349/month
The median standing price across the GLP-1 providers we track is about $169/month, so this is a premium, and a premium has to buy something. Discounting the first month does not change the twelve-month total by much.
MangoRx dispenses semaglutide and tirzepatide from $299/month, which makes it the honest comparison to run before committing here.
What Dr. Arevitalize dispenses
Dr. Arevitalize prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Dr. Arevitalize at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a demonstrated equal to the shot.
What we could verify
Dr. Arevitalize publishes little that can be checked from outside an intake. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You are optimizing for the twelve-month total rather than the first bill — a flat-rate seller such as CoreAge Rx will usually win that arithmetic.
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will be paying in month three.
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- you want a cheap way to find out whether the medication suits you before committing
- injections are the thing keeping you from starting
Our read
Dr. Arevitalize is a cheap way to start and an ordinary way to continue. Use the $269 month for what it is good for — establishing whether the medication works for you — and re-run the numbers against $319/month before you let it renew twice.
The Bottom Line
Dr. Arevitalize's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Before you pay Dr. Arevitalize
Starting at $269/month. Check today's price, then book the free consultation.
Where Dr. Arevitalize is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Dr. Arevitalize review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Dr. Arevitalize's current pricing
Plans start at $269/month. The free consultation is where you learn whether you qualify, and what it costs today.